| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fa68e585520dc37b645da3225a73cd34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27e1ea5f65e8f958e48f1a9d53fdbb45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_94a7694fb1a6c4a5d2bfe7f698014612 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C255-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D453-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D217-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-82 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D453-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D217-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C255-43 |
| filingDate |
2001-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90cc58726a7ea05d89755caf49fb3aff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37365f92eefb7e3206905b0cda2945c2 |
| publicationDate |
2001-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0181355-A1 |
| titleOfInvention |
Combretastatin a-1 phosphate and combretastatin b-1 phosphate prodrugs |
| abstract |
The present invention relates to the syntheses and structural elucidation of Combretastatin A1-Phosphate Prodrugs and Combretastatin B1-Phosphate Prodrugs and the utilization of those prodrugs in the treatment of neoplastic diseases. The prodrugs described herein have the structure: Combretastin A-1 Phosphate Prodrug (I) and Combretastin B-1 Phosphate Prodrug (II). |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009067706-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9040500-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10201623-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7648996-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE45907-E
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE45720-E
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8198302-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020247054-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10640508-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10918735-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011151423-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11535634-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8008318-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10918627-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7078552-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11174291-B2 |
| priorityDate |
2000-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |